Diffusion-weighted imaging in monitoring the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis
Abstract Background Diffusion-weighted imaging (DWI) is suggested as an non-invasive and non-radioactive imaging modality in the identification of pathological complete response (pCR) in breast cancer patients receiving neoadjuvant chemotherapy (NACT). A growing number of trials have been investigat...
Main Authors: | Wen Gao, Ning Guo, Ting Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12957-018-1438-y |
Similar Items
-
Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-, bi-, and stretched-exponential models
by: Shiteng Suo, et al.
Published: (2021-06-01) -
Role of breast ultrasound, mammography, magnetic resonance imaging and diffusion weighted imaging in predicting pathologic response of breast cancer after neoadjuvant chemotherapy
by: Manal Hamisa, et al.
Published: (2015-03-01) -
The Diagnostic Performance of DCE-MRI in Evaluating the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis
by: Qingqing Cheng, et al.
Published: (2020-02-01) -
Diffusion weighted imaging in early prediction of neoadjuvant chemotherapy response in breast cancer
by: Eman Abd Elrahim Mohamed El bakoury, et al.
Published: (2017-06-01) -
Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer
by: Fengling Li, et al.
Published: (2021-08-01)